New Zealand markets open in 7 hours 12 minutes

Amylyx Pharmaceuticals, Inc. (AMLX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.7700+0.0100 (+0.57%)
As of 10:47AM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
170,201
62,526
50,191
12,877
-
Other short-term investments
201,161
284,419
45,927
0
-
Total cash
371,362
346,945
96,118
12,877
-
Net receivables
40,050
15,306
0
-
-
Inventory
38,323
9,769
0
-
-
Other current assets
14,931
10,113
5,392
-
-
Total current assets
464,666
382,133
104,951
13,639
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
8,039
8,675
527
152
-
Accumulated depreciation
-1,628
-540
-53
-1
-
Net property, plant and equipment
6,411
8,135
474
151
-
Other long-term assets
46,377
1,185
189
314
-
Total non-current assets
52,788
9,320
663
465
-
Total assets
517,454
391,453
105,614
14,104
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
22,061
6,257
4,372
3,613
-
Accrued liabilities
40,934
23,081
8,744
1,858
-
Other current liabilities
-
4,596
-
-
-
Total current liabilities
82,042
46,609
17,396
7,326
-
Non-current liabilities
Long-term debt
-
-
-
1,425
14,931
Deferred revenues
-
-
-
14
4
Total non-current liabilities
1,980
4,237
239,386
73,503
-
Total liabilities
84,022
50,846
256,782
80,829
-
Stockholders' equity
Common stock
7
7
1
1
-
Retained earnings
-304,949
-354,220
-155,845
-67,914
-
Accumulated other comprehensive income
197
-86
9
0
-
Total stockholders' equity
433,432
340,607
-151,168
-66,725
-
Total liabilities and stockholders' equity
517,454
391,453
105,614
14,104
-